focus -WSS

focus

author：knowledge 2025-09-03 11:52:06 - browse：96984

Adam's take main illustration — Molly Ferguson/STAT

I am one week away from the launch of my weekly email newsletter! It’s called Adam’s Biotech Scorecard, and it’s exclusively for STAT subscribers. One catch: We need you to sign up, which you can do here. What should you expect to see in my newsletter each week? Unfiltered, uncompromising, and (hopefully) valuable insight and analysis from the intersection of Wall Street and biotech. Plus, a few dashes of fun.

Do you have a biotech-related question you want me to answer in the newsletter? Send me an email at [email protected].

This week: A preview of Intra-Cellular Therapies’ Phase 3 study in major depressive disorder, and a couple of liver-disease physician perspectives on Rezdiffra, the newly approved treatment for MASH from Madrigal Pharmaceuticals.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Psychedelics group wrestles with new pharma identity
Next article： STAT Boddities: What happens to the brain when we get scared?

Wikipedia

entertainment

WSS

Kim Kardashian sparks debate on benefits of full

AMAs digital advisors table RPM coding reform proposal, again

Report cites 'urgent' need to recruit more diverse clinical trial participants

GOP presidential candidates start declaring their loyalty

Congress considering partial increase for doctor pay in Medicare

'Disease catastrophe' looms in Sudan as health conditions deteriorate, medics warn

hotspot

focus

Wikipedia

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Readout Newsletter: Replicate, Biogen's Leqembi, and Humira

Cancer drug shortages should be causing more outrage

Listen: Your guide to Wegovy's blockbuster heart study

Hollywood unions extend contract negotiations for actors

Newly revealed memo details efforts to keep Trump in power following election loss

Bright Health sells Medicare Advantage business to Molina

Faced with fears of OxyContin misuse, sales reps touted its safety

The cancer drug shortage isn’t new — and neither are the solutions

Resistance to opioid

focus

STAT Boddities: What happens to the brain when we get scared?

Too many hospitalized Covid

Doctors on social media are being harassed and cyberbullied

Newly revealed memo details efforts to keep Trump in power following election loss

Covid's long

Websites selling Wegovy, Zepbound ingredients targeted by FDA

focus

Wikipedia

entertainment

explore